What's happening
Reference profile
Generated 13:14 ET
ATNM — Actinium Pharmaceuticals, Inc is up 19.5%, at 1.35, on $572.4K traded, 3.8× 20-day volume. Score 64. Primary driver: $0.6M traded. Supply intelligence: mixed supply · 64.
Get alerts on $ATNM
Halts, resumptions, new filings, and updated reports — in your inbox within minutes of the event.
Free · one email per event, no digests or spam · unsubscribe anytime · joins real followers
Free float
31.3M
2026-08-13
Shares out
31.4M
latest detail
Market cap
$35.5M
at ref price
Short interest
2.3%
2026-09-30
Float rotation
0.01×
latest snapshot
20d dollar vol
$125.7K
baseline
Gap quality
mixed supply · 64
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
nano-cap supply profile
detector reason
This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.
2026-10-19 13:10 ETSignalActinium Pharmaceuticals, Inc is up 19.5%, at 1.35, on $572.4K traded, 3.8× 20-day volume. Score 64. Primary driver: $0.6M traded. Supply intelligence: mixed supply · 64.
2026-10-158-KItem 5.02 — Director or officer departure/election/appointment; Item 7.01 — Regulation FD disclosure +1 more SEC
2026-08-148-KItem 3.01 — Notice of delisting or failure to satisfy listing rule; Item 7.01 — Regulation FD disclosure +1 more SEC
2026-05-298-KItem 3.01 — Notice of delisting or failure to satisfy listing rule; Item 7.01 — Regulation FD disclosure +1 more SEC
Latest detector signalscore 64